A&D Pharma gets delisted from London Stock Exchange

The Ad&D Pharma shareholders approved, in the Shareholders’ Extraordinary General Assembly, in early February, the company’s proposal for delisting from the London Stock Exchange, Antena 3 reports. The decision to remove the stocks from the stock market was made four years after the company was listed on the London market. At the time, A&D Pharma was evaluated at EUR 400 M. At present, the company’s estimated value is EUR 190 M. The company’s listing at the London Stock Exchange was decided upon hoping to obtain liquidity, but the action proved to be fruitless. The pharmaceutical group A&D Pharma includes four divisions, the retail one – Sensiblu, the distributor Mediplus, the medical services division Anima and A&D Pharma Marketing & Sales.

Related posts

Prysmian Group opened new optical cable plant in Romania

Sterling: Bucharest has cancelled right to share oil production


Zahal Levy, President of MediHelp International: In Romania there will be a basic health package with state and private health insurance

Leave a Comment